Skip to main content

Table 2 Response for patients treated with pemetrexed plus platinum (n = 53).

From: Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients

Response N (%) 95% CI (%)
CR - -
PR 7(13.2) 5.48 to 25.34
SD 36(67.9) 56.68 to 80.08
PD 10(18.9) 9.44 to 31.97
  1. CI, confidence interval; -, no data.